NCT01246401 Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Status COMPLETED Phase PHASE1/PHASE2
NCT01245101 Addition of Raltegravir to Established Antiretroviral Suppressive Therapy Status TERMINATED Phase PHASE4
NCT01241643 Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders Status TERMINATED Phase PHASE2
NCT01240486 IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites Status COMPLETED Phase N/A
NCT01236235 Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting Status COMPLETED Phase N/A
NCT01233531 Effects of Cash Transfer for the Prevention of HIV in Young South African Women Status COMPLETED Phase PHASE3
NCT01232361 IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents Status COMPLETED Phase N/A
NCT01232127 Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection Status COMPLETED Phase PHASE4
NCT01231685 Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection Status COMPLETED Phase PHASE2
NCT01225705 Safety Study of Raltegravir in HIV/HCV Co-infected Patients Status WITHDRAWN Phase PHASE4
NCT01214759 Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) Status COMPLETED Phase PHASE4
NCT01214486 Measurement of Plasma and Intracellular Concentrations of Raltegravir Status COMPLETED Phase NA
NCT01212042 Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections Status TERMINATED Phase N/A